American Association for Cancer Research

Poster Sessions

SUNDAY, APRIL 19
8:00 a.m.-12:00 p.m.

Prevention Research
Biological and Biochemical Mechanisms of Prevention
Diet and Cancer

Epidemiology
Nutrition, Physical Activity, and Cancer
Post Genome-wide Association Studies, Candidate Genes, Pathways, and Haplotypes

Tumor Biology
Angiogenesis Inhibitors 1
Angiogenesis Inhibitors 2
Cancer Stem Cells: Isolation and Characterization 1
Epithelial-Mesenchymal Transition in Cancer Progression and Metastasis
Hypoxia in the Microenvironment
Targets in the Microenvironment
Tumor Models
Tumor-Stromal Interactions

Immunology
Cancer Vaccines: Preclinical and Animal Models

Cellular and Molecular Biology
Autophagy
Caspases and IAPs
Cytoplasmic Signal Transducers
DNA Damage, Repair, and Genome Maintenance 1
Epigenetic Changes in Cancer
Cellular and Molecular Biology
Gene Expression in Cancer
MicroRNA/Noncoding RNA Expression in Cancer 1
MicroRNA/Noncoding RNA Expression in Cancer 2
Tumor Suppressors 1

Cancer Chemistry
Drug Delivery
Drug Design

Clinical Research
Biomarkers to Predict Treatment Response
Cancer Vaccines: Human Studies
Predictive Markers for Selecting Therapy

Carcinogenesis
Pathogen-Host Interaction and Transformation

Endocrinology
Endocrinology 1

Experimental and Molecular Therapeutics
Combination Chemotherapy 1
Kinases and Other Membrane Targets
Mechanisms of Drugs Based on p53 and Novel Cellular Pathways
P-glycoprotein and Non-P-glycoprotein Transporter Multidrug Resistance and Reversal

 

SUNDAY, APRIL 19
1:00 p.m.-5:00 p.m.

Prevention Research
Chemoprevention Studies 1
Chemoprevention Studies 2

Epidemiology
Descriptive Epidemiology, Cancer in Minorities, Childhood Cancer, and Methods
DNA Repair and Other Biomarkers Associated with Cancer Risk and Outcomes

Tumor Biology
Biomarkers of Tumor Metastasis
Cancer Stem Cells: Therapies and Chemoresistance
Cytokines and Chemokines in the Microenvironment
Extracellular Matrix and Proteases in Tumorigenesis
Innate Immune Response in Tumorigenesis
Metastasis Suppressor Genes

Carcinogenesis
Chemical and Environmental Carcinogenesis

Immunology
Antibody and Antibody Targets

Cellular and Molecular Biology
Cell Cycle 1
DNA Damage, Repair, and Genome Maintenance 2
Epigenetic Changes as Molecular Markers of Cancer 1
Growth Factors and Cell Surface-Related Oncogenes
MicroRNAs/Noncoding RNAs: Therapeutic Relevance and Biomarkers
Oncogenomics 1: Genome-wide DNA Alterations in Cancer
Oncogenomics 2: Genome-wide mRNA Profiling of Cancer
Survival and Death Signaling
Transcription Factors
Transcriptional Regulation

Cancer Chemistry
Chemistry 1

Clinical Research
Biomarkers for Cancer Diagnosis
Biomarkers for Outcome Prediction
Genomic Alterations
Issues Involving Clinical Research and Care

Experimental and Molecular Therapeutics
Agents Targeting Folate Pathway or Topoisomerases
Biochemical Modulators
Kinase Inhibitors 1
Novel Agents 1
Novel Agents 2
Protein Kinase and Other Inhibitors in Mechanism-Based Drug Cytotoxicity

 

MONDAY, APRIL 20
1:00 p.m.-5:00 p.m.

Prevention Research
Animal Models in Prevention

Epidemiology
Candidate Genes and Risk of Gastrointestinal and Prostate Cancers
Tobacco, Alcohol, Occupation, Medical Conditions, and Infections

Tumor Biology
Adhesion, Migration, and Invasion
Biology of Pediatric Cancer
Mediators of Tumor Progression, Invasion, and Metastasis 1
Mediators of Tumor Progression, Invasion, and Metastasis 2
Models of Tumor Progression, Invasion, and Metastasis
Radiosensitizers and Radioprotectors
Therapies in Mice

Carcinogenesis
Models and Mechanisms of Carcinogenesis

Endocrinology
Endocrinology 2

Immunology
Immune Modulating Antibodies and Lymphocyte Transfer

Cellular and Molecular Biology
Cancer Informatics 1
Cancer Informatics 2
Cell Cycle 2
Membrane Receptors and G Protein Signaling in Cancer
MicroRNAs/Noncoding RNAs in Cancer Biology
Molecular Markers
Oncogenomics 3: Non-coding RNAs, microRNAs, siRNAs, and Functional Genomics
Proteomic, Metabolomic, Cell, and Tissue Technologies
Regulation of MicroRNA/Noncoding RNA Expression, Functional Genomics, and Other Related Topics

Cancer Chemistry
Chemistry 2
Chemistry 3

Clinical Research
Prognostic Markers
Signal Transduction Pathways and Cancer Progression

Experimental and Molecular Therapeutics
Combination Targeted Therapy
IGF-IR and PI3K Pathways
Novel Molecular Targets for Therapy 1
Novel Molecular Targets for Therapy 2
Pharmacology, Pharmacogenetics, and Pharmacogenomics
Pharmacology, Pharmacokinetics, and Pharmacodynamics
Resistance to Antitubulin Drugs, Resistance to Platinums, and Glutathione Metabolism

 

TUESDAY, APRIL 21
8:00 a.m.-12:00 p.m.

Prevention Research
Molecular Targets for Cancer Prevention: New Agent Development
Prevention, Screening, and Clinical Biomarker Studies

Epidemiology
Biomarkers for DNA Alterations and Exposure in Biological Samples
Candidate Risk Genes: Melanoma, Hereditary Cancer Syndromes, and Rare and Childhood Cancers

Tumor Biology
Breast Cancer Stem Cells
Inhibition of Tumor Progression, Invasion, and Metastasis
Stem Cells and Tumorigenesis
Stem Cells: Biology and Potential Therapeutic Roles
Stromal Influence on Angiogenesis
Targets and Therapeutics in Pediatric Cancer 1
Tools for Discovery

Immunology
Immunotoxins, Immunoconjugates, and Antibody Combinations

Cellular and Molecular Biology
Bcl-2 Family
Cancer Systems Biology
Cell Cycle 3
Cloning and Functional Analysis of Cancer Genes
Epigenetic Changes as Molecular Markers of Cancer 2
Membrane Kinases, Phosphatases, and Signaling in Cancer Biology
Metabolism
Nuclear Oncoproteins and Tumor Suppressors
Senescence and Telomeres
Tissue Context Regulates Signaling to Modulate Cancer Progression and Treatment Response

Cancer Chemistry
Chemical Aspects of Carcinogenesis
Proteomics and Biomarker Discovery 1

Clinical Research
Clinical Trials 1
Early Clinical Trials
Translational Radiation Biology

Experimental and Molecular Therapeutics
Conjugates and Other Targeted Approaches
Drug Delivery Systems
Kinase Inhibitors 2
Kinase Inhibitors 3
NF-κB, Oxidative Stress, and Other Pathways in Cellular Drug Responses
Vector Systems and Targeting Strategies

 

TUESDAY, APRIL 21
1:00 p.m.-5:00 p.m.

Prevention Research
Biomarkers and Molecular Markers in Prevention

Epidemiology
Candidate Genes and Risk of Prostate, Women’s, and Tobacco-Related Cancers

Tumor Biology
Mechanisms of DNA Damage and Repair 1
Mechanisms of DNA Damage and Repair 2
Molecular Imaging of Cancer Biology and Therapeutic Response
Regulation of Angiogenesis
Targets and Therapeutics in Pediatric Cancer 2
VEGF and VEGF Receptors

Carcinogenesis
Molecular Carcinogenesis and DNA Damage

Endocrinology
Hormones and Cancer 2

Immunology
Tumor Immunology and Immune Manipulation 1
Tumor Immunology and Immune Manipulation 2

Cellular and Molecular Biology
Epidermal Growth Factor Receptors and Signaling in Cancer
Gene Expression and Promoter Analysis
Gene Functions in Cancer
Growth Factor Receptors and Signaling and Cancer Progression
Imaging Technologies and Applications
Molecular Cytogenetics and Mutation Detection
Oncogenes and Tumor Suppressors
Ras and Growth Factor Signaling in Cancer
Signaling Pathways
Tumor Suppressors 3

Cancer Chemistry
Imaging Agents and Radiotherapeutics
Proteomics and Biomarker Discovery 2

Clinical Research
Clinical Trials 2

Experimental and Molecular Therapeutics
Agents Causing DNA Damage or Proteasome Inhibition
Agents Targeting Histone Deacetylases and DNA Methyltransferase
Combination Chemotherapy 2
Drug Mechanisms Involving Cell Cycle, MAP Kinase, and Novel Targets
Gene and Vector-based Therapy
New Targets
Novel Agents 3
Resistance to Kinase Inhibitors and Hormonal Agents

 

WEDNESDAY, APRIL 22
8:00 a.m.-12:00 p.m.

Prevention Research
Behaviorial and Social Science in Cancer Prevention and Research

Epidemiology
Factors Affecting Cancer Survivorship
Medications, Hormones, Reproductive Factors, and Other Exposures

Tumor Biology
Cancer Stem Cells: Isolation and Characterization 2
Cooperating Oncogenic Events
Endogenous Metastasis Promoters and Inhibitors
Expression Profiling of Tumor Progression and Metastasis
Imaging the Cancer Metastasis Process
Novel Targets and Agents for Imaging Cancer

Carcinogenesis
Hormones, Signal Transduction, and Cancer

Immunology
Cytokines, Immune Modulation, and Immune Monitoring

Cellular and Molecular Biology
Cell Death and Chemotherapy
Death Receptors
DNA Methylation 1
DNA Methylation 2
Genomic Technologies and Applications
Intracellular Signaling in Cancer Progression
New Approaches and Technologies to Monitor Signaling in Cancer
Nuclear Receptors and Signaling in Cancer Progression and Therapy
Targeting Gene Expression in Cancer
Tumor Suppressors 4

Cancer Chemistry
Chemistry in Cancer: The Role of Protein and Nucleic Acid Interactions in Ligand Design
Molecular Pathway-Directed Tools and Agents for the Detection or Treatment of Cancer

Clinical Research
Novel Technologies in Cancer Biomarkers
Pharmacodynamic and Blood-Based Biomarkers
Pharmacokinetics and Pharmacodynamics of Early Clinical Trials

Experimental and Molecular Therapeutics
Antibody Technologies
Cell Death Pathways and Modulation of DNA Repair
Miscellaneous and Novel Mechanisms of Drug Resistance
Modulation of DNA Repair and Molecular Markers
Novel Agents 4
Preclinical Radiotherapeutics

 

BACK TO PROGRAM